SA 4503
| |
| |
| Nazivi | |
|---|---|
| IUPAC naziv
1-[2-(3,4-Dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine
| |
| Identifikacija | |
3D model (Jmol)
|
|
| |
| Svojstva | |
| C23H32N2O2 | |
| Molarna masa | 368,52 g·mol−1 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
 verifikuj (šta je   ?)
| |
| Reference infokutije | |
SA 4503 je agonist sigma receptora.[3][4]
Literatura
[уреди | уреди извор]- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ Matsuno K, Nakazawa M, Okamoto K, Kawashima Y, Mita S (1996). „Binding properties of SA4503, a novel and selective sigma 1 receptor agonist”. European journal of pharmacology. 306 (1-3): 271—9. PMID 8813641. doi:10.1016/0014-2999(96)00201-4.
- ^ Skuza G, Rogóz Z (2006). „The synergistic effect of selective sigma receptor agonists and uncompetitive NMDA receptor antagonists in the forced swim test in rats”. J. Physiol. Pharmacol. 57 (2): 217—29. PMID 16845227.
